EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Charcot Foot: An Update on Diagnosis, Treatment, and Areas of Uncertainty

Eleni Rebelos iD, Christos Siafarikas iD, Nikolaos Tentolouris, Edward B Jude iD

The International Journal of Lower Extremity Wounds · 2025

DOI: 10.1177/15347346241253451 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The International Journal of Lower Extremity Wounds, 2025. Verfasst von Eleni Rebelos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Turku PET Centre, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Arthropathy, Neurogenic, Diabetic Foot, Diabetic Neuropathies. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Charcot neuroosteoarthropathy (CN) is considered a rare complication of diabetic neuropathy. Due to its insidious mode of presentation, CN may be difficult to diagnose timely and a high index of suspicion is required from both, the diabetic patient (especially those with neuropathy) and their physicians for the early diagnosis and treatment to prevent major complications.

Methods

We planned a narrative review and searched MEDLINE database to identify evidence regarding CN incidence, treatment options, and recent guidelines. As practitioners do not commonly treat CN, a characteristic clinical case is also presented.

Results

The available evidence for diagnosis and treatment remains of low quality. On the one hand, there is an urgent need for action to increase awareness of the disease in both practitioners and people with diabetes. On the other hand, prospective nationwide registries of patients with diabetic neuropathy will help clarify the prognostic factors that may predispose to this complication, and more randomized clinical trials are needed to identify whether medical treatment may improve CN outcomes. For the time being, offloading of the foot to stop the perpetuation of trauma, and inflammation, and importantly to arrest the progression to a deformed nonfunctional foot is the cornerstone of medical therapy of CN. Multidisciplinary assessment between diabetologists and radiologists is fundamental for prompt diagnosis.

Conclusions

To avoid potentially deleterious delays in diagnosis and treatment, every physician should bear in mind that every patient with diabetic neuropathy presenting with a warm swollen foot should be treated as having CN until proven otherwise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthropathy, NeurogenicDiabetic FootDiabetic NeuropathiesHumansEarly Diagnosis

Stichwörter der Autor:innen

CT/MRdiagnosisoffloadingperipheral neuropathywound management

Autor:innen und Institutionen

  • Turku PET Centre, University of Turku, Turku, Finland.
  • First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
  • Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton under Lyne, UK.
  • University of Manchester, Manchester, UK.
  • Manchester Metropolitan University, Manchester, UK.

ORCID-Profile: Eleni Rebelos, Christos Siafarikas, Edward B Jude

Zitieren

APA

Rebelos, E., Siafarikas, C., Tentolouris, N., & Jude, E. B. (2025). Charcot Foot: An Update on Diagnosis, Treatment, and Areas of Uncertainty. The International Journal of Lower Extremity Wounds. https://doi.org/10.1177/15347346241253451

Vancouver

Rebelos E, Siafarikas C, Tentolouris N, Jude EB. Charcot Foot: An Update on Diagnosis, Treatment, and Areas of Uncertainty. The International Journal of Lower Extremity Wounds. 2025. doi:10.1177/15347346241253451

BibTeX
@article{Rebelos2025,
  author = {Rebelos, Eleni and Siafarikas, Christos and Tentolouris, Nikolaos and Jude, Edward B},
  title = {Charcot Foot: An Update on Diagnosis, Treatment, and Areas of Uncertainty},
  journal = {The International Journal of Lower Extremity Wounds},
  year = {2025},
  doi = {10.1177/15347346241253451}
}
Kostenlos starten →